Population pharmacokinetics and exposure‐response modeling analyses of guselkumab in patients with psoriatic arthritis

por Chen, Yang, Miao, Xin, Hsu, Chyi‐Hung, Zhuang, Yanli, Kollmeier, Alexa, Xu, Zhenhua, Zhou, Honghui, Sharma, Amarnath
Publicado 2021

Evaluating Potential Disease‐Mediated Protein‐Drug Interactions in Patients With Moderate‐to‐Severe Plaque Psoriasis Receiving Subcutaneous Guselkumab

por Zhu, Yaowei, Xu, Yan, Zhuang, Yanli, Piantone, Alexa, Shu, Cathye, Chen, Dion, Zhou, Honghui, Xu, Zhenhua, Sharma, Amarnath
Publicado 2020

Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome

por Zhang, Liping, Yan, Xiaoyu, Nandy, Partha, Willmann, Stefan, Fox, Keith A. A., Berkowitz, Scott D., Sharma, Amarnath, Hermanowski-Vosatka, Anne, Schmidt, Stephan, Weitz, Jeffrey I., Garmann, Dirk, Peters, Gary
Publicado 2019

Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma

por Girgis, Suzette, Lin, Shun Xin Wang, Pillarisetti, Kodandaram, Banerjee, Arnob, Stephenson, Tara, Ma, Xuewen, Shetty, Shoba, Yang, Tong-Yuan, Hilder, Brandi W., Jiao, Qun, Hanna, Brett, Adams, Homer C, Sun, Yu-Nien, Sharma, Amarnath, Smit, Jennifer, Infante, Jeffrey R., Goldberg, Jenna D., Elsayed, Yusri
Publicado 2022

Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma

por Girgis, Suzette, Lin, Shun Xin Wang, Pillarisetti, Kodandaram, Banerjee, Arnob, Stephenson, Tara, Ma, Xuewen, Shetty, Shoba, Yang, Tong-Yuan, Hilder, Brandi W., Jiao, Qun, Hanna, Brett, Adams, Homer C., Sun, Yu-Nien, Sharma, Amarnath, Smit, Jennifer, Infante, Jeffrey R., Goldberg, Jenna D., Elsayed, Yusri
Publicado 2022